Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 13/20 | 0.80 |
| ▸ | NTRK1 | P04629 | 4/20 | 0.71 |
| ▸ | BTK | Q06187 | 8/20 | 0.71 |
| ▸ | TXK | P42681 | 6/20 | 0.68 |
| ▸ | ITK | Q08881 | 4/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20161437 | 0.89 | JAK3 (1.00) | JAK3BTKTXKITK | |
| SCHEMBL29932937 | 0.89 | JAK3 (1.00) | JAK3BTKTXKITK | |
| SCHEMBL27089741 | 0.88 | JAK3 (0.80) | JAK3NTRK1BTKTXKITK | |
| SCHEMBL20139056 | 0.88 | JAK3 (0.78) | JAK3NTRK1BTKTXKITK | |
| SCHEMBL14461056 | 0.86 | ITK (0.84) | JAK3NTRK1BTKTXKITK | |
| SCHEMBL7002646 | 0.85 | NTRK1 (0.76) | JAK3NTRK1BTKTXKITK | |
| SCHEMBL29932944 | 0.85 | JAK3 (0.71) | JAK3NTRK1BTKTXKITK | |
| SCHEMBL20139064 | 0.85 | JAK3 (0.71) | JAK3NTRK1BTKTXKITK | |
| SCHEMBL20161866 | 0.85 | JAK3 (0.71) | JAK3NTRK1BTKTXKITK | |
| SCHEMBL23366056 | 0.84 | JAK3 (0.84) | JAK3NTRK1BTKTXKITK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3534899-B1 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | CORVUS PHARMACEUTICALS INC (US) | 2022-06-01 | — | — | EP | disclosed |
| WO-2018089261-A2 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | CORVUS PHARMACEUTICALS, INC. (US) | 2018-05-17 | — | — | WO | disclosed |